Impel NeuroPharma Funding: $250M Raised, IPO (2021)

Impel NeuroPharma is based in Seattle. It has raised $250M in total funding. Latest round: IPO. Backed by KKR, Norwest Venture Partners, 5AM Ventures.

Impel NeuroPharma funding overview

Impel NeuroPharma is based in Seattle. Impel NeuroPharma has raised $250M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in April 2021. The round record for Impel NeuroPharma runs through 2021; nothing later has been disclosed. Investors on record include KKR, Norwest Venture Partners, 5AM Ventures, Vivo Capital, VenBio Partners, Oaktree Capital Management. 6 distinct backers are named across the disclosed rounds.

Impel NeuroPharma at a glance

Total raised
$250M
Latest round
IPO
Latest round date
April 2021
Headquarters
Seattle
Notable investors
KKR, Norwest Venture Partners, 5AM Ventures, Vivo Capital, VenBio Partners, Oaktree Capital Management

Frequently asked about Impel NeuroPharma funding

How much has Impel NeuroPharma raised?
Impel NeuroPharma has raised $250M in total disclosed funding across the rounds on record.
Who has invested in Impel NeuroPharma?
KKR, Norwest Venture Partners, 5AM Ventures, Vivo Capital, VenBio Partners, Oaktree Capital Management are named among the investors backing Impel NeuroPharma.
What was the latest Impel NeuroPharma funding round?
The most recent disclosed round is an IPO, announced in April 2021.
Where is Impel NeuroPharma based?
Impel NeuroPharma is based in Seattle.
When did Impel NeuroPharma last raise?
The last disclosed Impel NeuroPharma round closed in April 2021 at IPO.

Impel NeuroPharma totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Seattle below to benchmark round size and investor mix.

Companies related to Impel NeuroPharma (36)

Browse related funding lists (10)

Company funding database · Investor directory · Founder database · Mega-rounds 2026